title: [Monoclonal antibodies in diagnosis and therapy].
abstract: The value of monoclonal antibodies (mAb) produced against renal, bladder and prostate cancer antigens is demonstrated. These mAb allow a molecular classification of urological cancers as well as therapeutic approaches in cancer treatment. Anti-T-cell mAb can also be used in cellular rejection of kidney transplants.
authors.affiliation: Urologische Klinik, FU Berlin, Klinikum Steglitz.
authors.forename: H
authors.initials: H
authors.lastname: Huland
authors.forename: P
authors.initials: P
authors.lastname: Hammerer
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D000951:Antigens, Neoplasm / Q000276:immunology*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000628:therapy
chemical_list: D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000951:Antigens, Neoplasm
vernacular_title: Monoklonale Antikörper in Diagnostik und Therapie.